84 filings
Page 3 of 5
6-K
vr0t dz2iz
12 Apr 22
BriaCell Presents Development Details of Bria-OTS™ Platform Technology at the American Association for Cancer Research (AACR) Annual Meeting 2022
4:57pm
6-K
6e9 6e8rq
7 Apr 22
BriaCell advances preparatory work for new Bria-OTS™ breast cancer clinical trial
8:35am
6-K
nyzk0my485 aj
15 Mar 22
Current report (foreign)
4:56pm
6-K
7sg8sefc6e4nw44zp7
28 Feb 22
BriaCell Adds Two Clinical Trial Sites to Accelerate Patient Enrollment
4:30pm
6-K
o9f0xap zehyv06orh7
23 Feb 22
BriaCell Appoints Leading Immunologist Dr. Alexander Kharazi to its Scientific Advisory Board
4:05pm
6-K
m6c 0kcphvbd3bt
16 Feb 22
BriaCell Appoints Renowned Oncologist, Giuseppe Del Priore, MD, MPH, as Chief Medical Officer
5:30pm
6-K
qcryo9raap7n0zt
10 Feb 22
BriaCell to Present at the AACR 2022; Provides Corporate Buyback and Insider Buying Update
4:05pm
6-K
krwhxm
20 Jan 22
BriaCell Therapeutics Corp. Announces Results of 2022 Annual and Special Meeting of Shareholders
6:01am
6-K
35pa1evil9i 0e
5 Jan 22
Notice of Annual General and Special Meeting
12:00am
6-K
9xdlpaebugrthwwrsiy
30 Dec 21
BriaCell to Uplist and Trade on the Toronto Stock Exchange from TSX Venture Exchange under ‘BCT’; Remains ‘BCTX’ on Nasdaq
4:00pm
6-K
wl76s4gdkx5 i8r75
17 Dec 21
BriaCell Announces Insiders’ Intention to Purchase up to 10% of Public Market Securities
12:00am
6-K
arbhx4f
15 Dec 21
Condensed Interim Consolidated Financial Statements
11:37am
6-K
d3u99ja3 fobzc7nic
9 Dec 21
Current report (foreign)
4:01pm
6-K
pqo9q1bshgpqh jo
19 Nov 21
BriaCell Adds Mary Crowley Cancer Research Center as a Clinical Trial Site for its Phase I/IIa Breast Cancer Study
12:00am
6-K
kpfio7ztdfsqir3ow
12 Nov 21
BriaCell Announces Update on Previously Announced Securities Buyback Program and Participation at Upcoming Conferences
4:43pm
6-K
ua1wh
5 Nov 21
BriaCell Adds Pioneering Immunologist and Cancer Immunotherapy Expert, Suzanne Ostrand-Rosenberg, Ph.D., to its Scientific Advisory Board
4:05pm
6-K
h045193
2 Nov 21
BriaCell Appoints Renowned Pharmaceutical Veteran Jane Gross, Ph.D. to its Board of Directors
4:05pm
6-K
xt08rj9 82ae
29 Oct 21
Consolidated Financial Statements
4:05pm
6-K
in5r7k a4t04gk
5 Oct 21
October is Breast Cancer Awareness Month – BriaCell is Advancing the Fight with its Immunotherapy
4:05pm
6-K
bee90tidu94mqr5gu
22 Sep 21
BriaCell Announces TSXV Acceptance of Normal Course Issuer Bid
4:05pm